Clear ×
Skye Bioscience, Inc. SKYE

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 11, 2026 8-K 2 signals fired
Other
Nasdaq Minimum Bid Price Delisting Notice
Core
Management Exodus
Aug 24, 2026 8-K 20 signals fired · top 15
Other
New York Jurisdiction Clause Market Price Definition Corporate Authority Representation Amendment Modification Waiver Clause Corporate Organization And Standing Representation Indemnification Consent Requirement Conflicted Defense Counsel Provision Form 8K Filing Disclosure Survival Of Representations Warranties Clause Fcpa Compliance Representation Registration Rights Piggyback Provision No Broker Fees Representation Closing Deliverables Specified Registrant Bears Registration Expenses Stock Option Exercise Payment Method Disclosure
Aug 18, 2026 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
Aug 14, 2026 8-K 71 signals fired · top 15
Other
Corporate Organization And Standing Representation Reverse Stock Split Effected Merger Proxy Statement Disclosure Indemnification Consent Requirement Earnings Call Qa Segment Corporate Authority Representation Fcpa Compliance Representation Interim Data Positive Registration Rights Piggyback Provision Sanctions Compliance Representation Amendment Modification Waiver Clause Hazardous Materials Definition Conflicted Defense Counsel Provision Board Committee Member Listing
Core
Clinical Trial Result
Aug 14, 2026 10-Q 37 signals fired · top 15
Other
Reverse Stock Split Effected Nyse Listing Disclosure Nasdaq Minimum Bid Price Delisting Notice Market Volatility Risk Disclosure Net Loss Reported Stock Price As Of Filing Date Other Income Expense Disclosure Restrictive Debt Covenants Disclosure Competition Disclosure Goodwill Impairment Capital Raising Uncertainty Disclosed Personnel Cost Decrease Disclosure Cash Flow Statement Investing Activities Shares Outstanding Disclosure Administrative Efficiency
Jun 22, 2026 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
May 29, 2026 8-K 5 signals fired
Other
Say On Pay Vote Result Disclosed Classified Board Director Election Adjournment Proposal Voting Requirement Equity Plan Board Approval Conditional On Shareholder Vote Quorum Presence Disclosed
May 15, 2026 8-K 1 signal fired
Other
Nasdaq Minimum Bid Price Delisting Notice
May 11, 2026 10-Q 36 signals fired · top 15
Other
Nyse Listing Disclosure Net Loss Reported Capital Raising Uncertainty Disclosed Reverse Stock Split Effected Other Income Expense Disclosure Nasdaq Minimum Bid Price Delisting Notice Cash Flow Statement Investing Activities Personnel Cost Decrease Disclosure Shares Outstanding Disclosure Interim Data Positive Financing Activities Cash Flow Disclosure Burn Rate Controlled Administrative Efficiency
Core
Clinical Trial Result Indication Expansion
Apr 3, 2026 8-K 13 signals fired
Other
Executive Educational Background Disclosure Confidential Information Return Obligation Non Assignment Clause Termination For Material Breach Clause New York Jurisdiction Clause Non Solicitation Covenant Amendment Modification Waiver Clause Indemnification Consent Requirement Registrant Bears Registration Expenses Director Officer Indemnification Provision Transfer And Demand Rights Limitations Stock Option Grant Disclosed Conflicted Defense Counsel Provision